Description
PRINCIPIO ACTIVO: VORTIOXETINA
Tratamiento de carcinoma renal avanzado tras terapia con inhibidor de tirosina quinasa
HMO (2’-FL) Presentación: Lata con 800 g Este producto no es un medicamento
FORMA FARMACÉUTICA: 5 SUPOSITORIOS
DOSTINEX® 0
JBN N-D ANTIB P/MANO MDNA 500ML GENERICOPSICOFARMA SADE CV PRINCIPIO ACTIVO: VORTIOXETINA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
